Video-electroencephalography in conscious non human primate using radiotelemetry and computerized analysis: Refinement of a safety pharmacology model

Journal of Pharmacological and Toxicological Methods

Volumn 60, Issue 1, 2009, Pages 88-93

  Authier, S ^a,b   Paquette, D ^a   Gauvin, D ^b   Sammut, V ^a   Fournier, S ^a   Chaurand, F ^a   Troncy, E ^b  

^a LAB Research Inc   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Conscious; Electroencephalography; Monkey; Pentylenetetrazole; Pharmacology; Safety; Seizure

Indexed keywords

DIAZEPAM; PENTETRAZOLE;

ALPHA RHYTHM; AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA RHYTHM; COMPUTER ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; CONVULSION; DELTA RHYTHM; DRUG SAFETY; ELECTRODE; ELECTROENCEPHALOGRAPHY; FOURIER TRANSFORMATION; GRAND MAL SEIZURE; MONITORING; MONKEY; NONHUMAN; SEIZURE; SLEEP STAGE; SPECTROSCOPY; SPIKE; TELEMETRY; THETA RHYTHM; VIDEORECORDING; VISUAL STIMULATION;

ANIMALS; CONVULSANTS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; ELECTROENCEPHALOGRAPHY; EQUIPMENT DESIGN; MACACA FASCICULARIS; PENTYLENETETRAZOLE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SEIZURES; SIGNAL PROCESSING, COMPUTER-ASSISTED; TELEMETRY; VIDEO RECORDING;

ANIMALIA; MACACA FASCICULARIS; PRIMATES; RODENTIA;

EID: 68549125190     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vascn.2008.12.003     Document Type: Article

References (26)

1. Ambrani L.M., and Van Woert M.H. Modification of the tremorigenic activity of physostigmine. British Journal of Pharmacology 46 (1972) 344-347
2. Almirall H., Pigarev I., De la Calzada M.D., Pigareva M., Herrero M.T., and Sagales T. Nocturnal sleep structure and temperature slope in MPTP treated monkeys. Journal of Neural Transmission 106 (1999) 1125-1134
3. Asano E., Pawlak C., Shah A., Shah J., Luat A.F., Ahn-Ewing J., et al. The diagnostic value of initial video-EEG monitoring in children-review of 1000 cases. Epilepsy Research 66 (2005) 129-135
4. Bastien C.H., Leblanc M., Carrier J., and Morin C.M. Sleep EEG power spectra, insomnia, and chronic use of benzodiazepines. Sleep 26 (2003) 313-317
5. Cherubini E., Gonella J., Mancia D., Mecarelli O., and Tassinari C.A. Effects of PTZ-induced generalized epilepsy on intestinal activity in cats. Epilepsia 22 (1981) 309-314
6. Danielsen J., and Ellebjerg J. Comparable EEG activation by megimide and metrazol. Epilepsia 7 (1966) 228-232
7. Danielsson I., Gasior M., Stevenson G.W., Folk J.E., Rice K.C., and Negus S.S. Electroencephalographic and convulsant effects of the delta opioid agonist SNC80 in rhesus monkeys. Pharmacology, Biochemistry and Behavior 85 (2006) 428-434
8. David J., and Grewal R.S. Induction of seizures with pentylenetetrazol in Macaca mulatta. Photic and pentylenetetrazol-induced seizure susceptibility in Macaca mulatta. Journal of Medical Primatology 6 (1977) 337-343
9. Durmuller N., Guillaume P., Lacroix P., Porsolt R.D., and Moser P. The use of the dog electroencephalogram (EEG) in safety pharmacology to evaluate proconvulsant risk. Journal Pharmacological and Toxicological Methods 56 (2007) 234-238
10. Feige B., Voderholzer U., Riemann D., Dittmann R., Hohagen F., and Berger M. Fluoxetine and sleep EEG: Effects of a single dose, subchronic treatment, and discontinuation in healthy subjects. Neuropsychopharmacology 26 (2002) 246-258
11. Gianotti L.R., Kunig G., Faber P.L., Lehmann D., Pascual-Marqui R.D., Kochi K., et al. Rivastigmine effects on EEG spectra and three-dimensional LORETA functional imaging in Alzheimer's disease. Psychopharmacology (Berl) 198 (2008) 323-332
12. Hughes B. FDA drug approvals: A year of flux. Nature Reviews Drug Discovery 7 (2008) 107-109 2007
13. Jurko M.F., and Andy O.J. Comparative EEG frequencies in rhesus, stumptail, and cynomolgus monkeys. Electroencephalography Clinical Neurophysiology 23 (1967) 270-272
14. Lahunta A., Glass E.N., and Kent M. Classifying involuntary muscle contractions. Compendium Continuous Education Practicing Veterinarians 28 (2006) 516-530
15. Lallement G., Clarencon D., Masqueliez C., Baubichon D., Galonnier M., Burckhart M.F., et al. Nerve agent poisoning in primates: Antilethal, anti-epileptic and neuroprotective effects of GK-11. Archives of Toxicology 72 (1998) 84-92
16. Mirski M.A., Tsai Y.C., Rossell L.A., Thakor N.V., and Sherman D.L. Anterior thalamic mediation of experimental seizures: Selective EEG spectral coherence. Epilepsia 44 (2003) 355-365
17. Morisson F., Lavigne G., Petit D., Nielsen T., Malo J., and Montplaisir J. Spectral analysis of wakefulness and REM sleep EEG in patients with sleep apnoea syndrome. The European Respiratory Journal 11 (1998) 1135-1140
18. Oldham H.G., Standring P., Norman S.J., Blake T.J., Beattie I., Cox P.J., et al. Metabolism of temelastine (SK&F 93944) in hepatocytes from rat, dog, cynomolgus monkey and man. Drug Metabolism and Disposition 18 (1990) 146-152
19. Poupard L., Sartene R., and Wallet J.C. Scaling behavior in beta-wave amplitude modulation and its relationship to alertness. Biological Cybernetics 85 (2001) 19-26
20. Pearce P.C., Crofts H.S., Muggleton N.G., and Scott E.A. Concurrent monitoring of EEG and performance in the common marmoset: A methodological approach. Physiology & Behavior 15 (1998) 591-599
21. Rowan J.A., and Tolunsky E. Primer of EEG (2003), Butterworth Heinemann, Philadelphia, PA
22. Sharbrough F., Chatrian G.E., Lesser R.P., Luders H., Nuwer M., and Picton T.W. American Electroencephalographic Society guidelines for standard electrode position nomenclature. Journal of Clinical Neurophysiology 8 (1991) 200-202
23. Thomsen T., Kewitz H., and Pleul O. Estimation of cholinesterase activity (EC 3.1.1.7; 3.1.1.8) in undiluted plasma and erythrocytes as a tool for measuring in vivo effects of reversible inhibitors. Journal of Clinical Chemistry and Clinical Biochemistry 26 (1988) 469-475
24. Tilz C., Stefan H., Hopfengaertner R., Kerling F., Genow A., and Wang-Tilz Y. Influence of levetiracetame on ictal and postictal EEG in patients with partial seizures. European Journal of Neurology 13 (2006) 1352-1358
25. U.S. Food and Drug Administration. (2001). Guidance for industry: Safety pharmacology studies for human pharmaceuticals (S7A). http://www.fda.gov/cber/gdlns/ichs7a071201.htm
26. Wu X., and Xiao C.H. Quantitative pharmaco-EEG of carbamazepine in volunteers and epileptics. Clinical Electroencephalography 27 (1996) 40-45